Sublingual Immunotherapy for Allergic Rhinitis: Is 2-Year Treatment Sufficient for Long-term Benefit?
- PMID: 28196239
- DOI: 10.1001/jama.2017.0128
Sublingual Immunotherapy for Allergic Rhinitis: Is 2-Year Treatment Sufficient for Long-term Benefit?
Erratum in
-
Misstated Text.JAMA. 2017 Mar 21;317(11):1179. doi: 10.1001/jama.2017.1785. JAMA. 2017. PMID: 28241213 No abstract available.
Comment on
-
Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.JAMA. 2017 Feb 14;317(6):615-625. doi: 10.1001/jama.2016.21040. JAMA. 2017. PMID: 28196255 Free PMC article. Clinical Trial.
Similar articles
-
Sublingual or subcutaneous immunotherapy for allergic rhinitis?J Allergy Clin Immunol. 2016 Feb;137(2):339-349.e10. doi: 10.1016/j.jaci.2015.12.1298. J Allergy Clin Immunol. 2016. PMID: 26853126 Review.
-
Efficacy and Safety of Subcutaneous and Sublingual Immunotherapy for Allergic Rhinoconjunctivitis and Asthma.Otolaryngol Clin North Am. 2017 Dec;50(6):1111-1119. doi: 10.1016/j.otc.2017.08.011. Epub 2017 Sep 28. Otolaryngol Clin North Am. 2017. PMID: 28964530 Review.
-
Subcutaneous versus sublingual immunotherapy.Expert Rev Clin Immunol. 2016 Aug;12(8):801-3. doi: 10.1080/1744666X.2016.1196137. Epub 2016 Jun 16. Expert Rev Clin Immunol. 2016. PMID: 27253418 No abstract available.
-
[Efficacy of the dust mites drops sublingual immunotherapy in pediatric allergic rhinitis].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Mar;30(5):357-60. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016. PMID: 27382674 Clinical Trial. Chinese.
-
Clinical Applications of Sublingual Immunotherapy.Otolaryngol Clin North Am. 2017 Dec;50(6):1121-1134. doi: 10.1016/j.otc.2017.08.010. Otolaryngol Clin North Am. 2017. PMID: 29103453 Review.
Cited by
-
Modelling the impact of sublingual immunotherapy versus subcutaneous immunotherapy on patient travel time and CO2 emissions in Sweden.Sci Rep. 2024 Jan 18;14(1):1575. doi: 10.1038/s41598-024-51925-8. Sci Rep. 2024. PMID: 38238479 Free PMC article.
-
Identification of key genes and the pathophysiology associated with allergen-specific immunotherapy for allergic rhinitis.BMC Immunol. 2023 Jul 10;24(1):19. doi: 10.1186/s12865-023-00556-1. BMC Immunol. 2023. PMID: 37430199 Free PMC article.
-
Evaluation of the quality of guidelines for sublingual immunotherapy of allergic rhinitis.Eur Arch Otorhinolaryngol. 2023 Oct;280(10):4319-4325. doi: 10.1007/s00405-023-08083-w. Epub 2023 Jul 6. Eur Arch Otorhinolaryngol. 2023. PMID: 37410146 Review.
-
Subcutaneous allergen immunotherapy for asthma: A randomized, double-blind, placebo-controlled study with a standardized Blomia tropicalis vaccine.World Allergy Organ J. 2020 Apr 10;13(4):100098. doi: 10.1016/j.waojou.2020.100098. eCollection 2020 Apr. World Allergy Organ J. 2020. PMID: 32308779 Free PMC article.
-
Exploration of the Molecular Mechanism of FUZI (Aconiti Lateralis Radix Praeparata) in Allergic Rhinitis Treatment Based on Network Pharmacology.Med Sci Monit. 2020 Mar 1;26:e920872. doi: 10.12659/MSM.920872. Med Sci Monit. 2020. PMID: 32114589 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
